Researchers at Indiana University School of Medicine are looking for 400 people with type 1 diabetes to volunteer for a study of an inhaled insulin treatment.研究人员在印第安纳大学医学院的现正追缉400人，与1型糖尿病的义工，进行一项研究，一个吸入式胰岛素治疗。

The Indiana University School of Medicine is one of 70 sites around the world testing the treatment developed by Indianapolis-based Eli Lilly and Co.印第安纳大学医学院的是一个70的网站在世界各地的测试治疗开发的印第安纳波利斯为基础的礼来公司

Requirements:要求：
Participants must be type 1 diabetes patients who rely on an insulin shot before two meals per day.参加者必须是1型糖尿病病人谁依赖于胰岛素开枪之前，两个三餐，每天。 They cannot be on an insulin pump, smoke or suffer from asthma or any other lung disorder.他们不能对一个胰岛素泵，烟雾或罹患哮喘或任何其他肺疾病。

Over two years, study participants will inhale insulin rather than getting it from needles.两年多来，研究参加者将吸入胰岛素，而非越来越从针头。

Benefit:好处：
If the inhaler proves to be safe and effective, it could hit the market by the end of this year.如果吸入证明是安全和有效，它可以击中市场在今年年底。

In a previous phase of the clinical trial, researchers determined that the inhaler controlled blood-sugar levels just as well as insulin shots.在以前的阶段的临床试验，研究人员发现，吸入控制血糖水平，正如以及胰岛素枪。

To volunteer for the study, call (317) 274-3948.义工的研究，电话： （ 317 ） 274-3948 。

Source来源